GENE ONLINE|News &
Opinion
Blog

China
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
Finland’s Orion Strikes for Jemincare’s Non-Opioid Painkiller, Paying $15 Million Upfront
2022-05-09
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
AstraZeneca Taps China’s AmoyDx for Companion Diagnostics
2022-04-19
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
Helsinn Group Gains Marketing Rights to BridgeBio’s Truseltiq in the US
2022-03-04
Sanofi Bets $2.5 billion on Adagene to Make Antibodies Safer
2022-03-03
China Pushes for Faster Approval for Gene-Edited Crops
2022-02-15
1 2 3 4 8
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top